Medical and Pharmaceutical NHS lung cancer screening pilot combines power of AI software and robotic bronchoscopy Optellum's AI detects nodules and Intuitive Surgical's device performs a precision biopsy Rowan DunneJanuary 28, 2026
Medical and Pharmaceutical Leading oncology organizations condemn ‘misinformation’ about lung cancer screening dangers One widely cited study was apparently relying on data from Japanese atomic bomb survivors Rowan DunneJanuary 26, 2026
Medical and Pharmaceutical Bristol Myers Squibb teams up with Microsoft for AI-powered lung cancer detection Artificial intelligence has been transforming healthcare in many regards Rowan DunneJanuary 21, 2026
Medical and Pharmaceutical NFL veterans join the fight against lung cancer Their new initiative originally focused on colorectal cancer and has now expanded to lung Rowan DunneJanuary 11, 2026
Medical and Pharmaceutical UAE plans to make cancer screening mandatory nationwide By doing so, the nation seeks to reduce the burden on its healthcare sector Rowan DunneJanuary 7, 2026
Medical and Pharmaceutical New York Governor Kathy Hochul signs legislation making lung cancer screening free Healthcare insurance providers are now mandated to provide the service free of charge Rowan DunneDecember 9, 2025
Medical and Pharmaceutical Lung Cancer Research Foundation awards 11 with US$1.65M grant Prevention, early detection and fighting treatment resistance were key funding focuses Rowan DunneDecember 8, 2025
Medical and Pharmaceutical Breath Diagnostics completes install of advanced mass spectrometry system The medtech company is one of the first to adopt the Xevo TQ Absolute XR Rowan DunneDecember 3, 2025
Medical and Pharmaceutical BioMark Diagnostics receives Innovation Award for lung cancer screening project It acknowledges the company’s development of an efficacious blood biopsy Rowan DunneDecember 3, 2025
Medical and Pharmaceutical Northwestern Medicine breaks new ground by offering lung screening to young people The Chicago healthcare system says eligibility criteria needs to be expanded significantly Rowan DunneDecember 1, 2025